Abstracts from 2014 through the most recent CROI can be viewed in this searchable database once they have been presented at the conference. Abstract Contents: The searchable database includes abstract text as submitted by the authors prior to CROI. Study data might be updated during the presentation at CROI. Please refer to the electronic poster or webcast for updates. Searching the Abstract Database: Enter the criteria below and click the “Search” button. After the search has been entered, the results will appear below the search form.

CROI conference materials (eg, the conference program, Abstract eBook, electronic posters, CROI logo, etc) are protected by copyright. Permission to replicate or reproduce these elements, in whole or in part, must be obtained from the CROI Conference Manager, the International Antiviral Society-USA (IAS-USA). Study data (including figures within abstracts or electronic posters) are the property of the study authors. Permission to use data and figures cannot be given by IAS–USA unless it is for regulatory reasons. For more information, please email CROIabstracts@iasusa.org.

Search Results

1277 Results

1179 – Estimating Need for Annual HIV Testing Met by a Nationwide Mailed HIV Self-Testing Program

Background The Together TakeMeHome program (TTMH) provides free HIV self-test kits (HIVSTs) by mail, allowing people at least 17 years old who may experience barriers to accessing other HIV testing services to test privately on their own time. Users can order one or two HIVSTs. Our goal was to use nationally representative survey data to…

1181 – Moderators of a Home-Based Couple Intervention on Couple HIV Testing and Counselling Uptake in Kenya

Background Identifying individuals who require particular strategies or possess characteristics for which the interventions are most effective is critical for achieving personalized care and optimal impact. We sought to identify and assess moderators of a home-based couples intervention on uptake of couple HIV testing and counselling (CHTC) in southwestern Kenya. Methods In a randomized control…

1110 – Time to Antiretroviral Initiation Among Transgender Women Living With HIV in France (1997-2022)

Background Despite a global HIV prevalence of nearly 20% among transgender women (TW), some studies have shown that this population often experiences longer time intervals within the continuum of care. This study aims to describe the evolution of these time intervals and analyze the impact of sociodemographic and clinical factors on the time to antiretroviral…

1108 – Recent HIV Acquisition Among Transgender Women From Midwest Brazil

Background In Brazil, transgender women (TGW) face a disproportionately high burden of HIV. Research on the patterns of the HIV epidemic in TGW is still lacking in Midwest Brazil. We aimed to evaluate the HIV prevalence and proportion of recent HIV acquisition and to explore factors associated with recent HIV acquisition among TGW from Goiás, Brazil.…

1109 – High HIV Burden Among Transgender Women in the State Capital and Rural Towns in Central Brazil

Background Transgender women (TGW) have an increased risk for HIV due to social exclusion, barriers to access to health care, discrimination, and exposure to higher-risk contexts such as sex work. In fact, there is a lack of studies assessing the dynamics of the HIV epidemic among TGW in rural cities. This is a cross-sectional study that…

1021 – Growth Faltering Is Partially Ameliorated by Infant Gut Bifidobacterium in Children Exposed to HIV

Background Children with HIV exposure (CHEU) who do not experience HIV infection are at increased risk of growth faltering compared to children unexposed to HIV (CHU). Decreased abundance of Bifidobacterium has been associated with growth faltering in CHEU. We examined the gut microbiota of CHEU versus CHU to determine if specific microbes may influence growth…

1023 – Cardiometabolic Outcomes in HEU vs HU Children in a SA Birth Cohort: Influence of Maternal Lipids

Background HIV-Exposed Uninfected (HEU) children have worse cardiometabolic health outcomes, compared to HIV-Unexposed uninfected (HU) children, but the effect of maternal cardiometabolic health in pregnancy on child outcomes is not clear. Our study investigated the impact of maternal gestational lipid biomarkers on child cardiometabolic health indicators in a birth cohort of South African HEU and…

1022 – Insulin-Like Growth Factors and Stunting in African Infants Exposed to HIV and Uninfected

Background The biological mechanisms related to increased risk of stunting in infants/children who are HIV-exposed and uninfected (CHEU) are not fully clear. We assessed whether insulin-like growth factors (IGFs), which are associated with infant growth, are determinants for stunting observed among CHEU. Methods A random sample of 213 out of 268 infants from the antepartum part of the IMPAACT P1084s…

940 – Plasma Biomarkers in Children and Young People With Long COVID

Background Although most patients infected with SARS-CoV-2 recover, 10-20% can develop long-term persistent symptoms after the acute infection, a condition known as long COVID or Post-Acute Sequalae of SARS-CoV-2 (PASC). In this study we aim to compare autoantibodies, cytokines and  neuronal and vascular damage biomarkers in plasma from  children and young people (CYP) with and…

1024 – Obesity and Metabolic Comorbidities in Young Adults With Perinatal HIV Exposure Without Infection

Background The global scale-up of prenatal antiretroviral therapy (ART) has reduced the vertical transmission of HIV to <1%. In this context, a growing population of individuals with perinatal HIV exposure without infection (PHEU) has emerged, which now exceeds 20 million people worldwide. While growing evidence indicates that infants and children with PHEU are at increased…